Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2025 Filed Sep 11, 2025 18:55 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 96 | $116.34 | $11,168.64 |
DisclosureSEC source: 0001193125-25-201224 · ownership.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,758 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:55 UTC |
Hunt AnthonyDirector
|
Exercise / conversionCommon Stock | 20,000 | $33.87 | $677,400.00 |
DisclosureSEC source: 0001193125-25-201224 · ownership.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 14:55 UTC |
Loeillot OlivierDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,506 | $116.18 | $291,147.08 |
DisclosureSEC source: 0001193125-25-195655 · ownership.xml · nonDerivative · entry 1 Loeillot Olivier · CIK 0001995525 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,187 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 16:47 UTC |
Hughes ViolettaCHIEF ACCOUNTING OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 3,914 | $0.00 Strike: $120.69 | $0.00 |
DisclosureSEC source: 0000950170-25-112985 · ownership.xml · derivative · entry 2 Hughes Violetta · CIK 0001991429 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,914 Underlying: Common Stock · 3,914 shares Expires 2035-09-02 F2 · derivative.exercise_date: The shares vest in equal annual instalments over a five-year period with each such vesting date occurring on the anniversary of the grant date. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 16:47 UTC |
Hughes ViolettaCHIEF ACCOUNTING OFFICER
|
GrantCommon Stock | 4,142 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-112985 · ownership.xml · nonDerivative · entry 1 Hughes Violetta · CIK 0001991429 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,142 F1 · shares: Ms. Hughes was awarded 4,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a five-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 16:47 UTC |
Madaus Martin DDirector
|
PurchaseCommon Stock | 1,800 | $112.13 | $201,830.40 |
DisclosureSEC source: 0000950170-25-107084 · ownership.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Martin D. Madaus 2011 Revocable Trust Disclosed balance after: 1,800 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.72 to $112.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:02 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 7 | $127.00 | $889.00 |
DisclosureSEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 5 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,854 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:02 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 268 | $125.20 | $33,553.60 |
DisclosureSEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 4 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,861 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F5 · price: $125.20 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.06 to $126.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:02 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 6,533 | $124.34 | $812,313.22 |
DisclosureSEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,129 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F4 · price: $124.34 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.05 to $125.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:02 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 17,596 | $123.57 | $2,174,337.72 |
DisclosureSEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,662 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F3 · price: $123.57 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.04 to $124.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:02 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 2,043 | $122.66 | $250,594.38 |
DisclosureSEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,258 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F2 · price: $122.66 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.03 to $123.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:26 UTC |
Konstantinov KonstantinDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074761 · ownership.xml · derivative · entry 2 Konstantinov Konstantin · CIK 0001774649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:26 UTC |
Konstantinov KonstantinDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074761 · ownership.xml · nonDerivative · entry 1 Konstantinov Konstantin · CIK 0001774649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,894 F1 · shares: Mr. Konstantinov was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:19 UTC |
MUIR GLENN PDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074752 · ownership.xml · derivative · entry 2 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:19 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074752 · ownership.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,256 F1 · shares: Mr. Muir was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:16 UTC |
EGLINTON MANNER CARRIEDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074747 · ownership.xml · derivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:16 UTC |
EGLINTON MANNER CARRIEDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074747 · ownership.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,466 F1 · shares: Ms. Manner was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 19, 2025 19:27 UTC |
DAWES KAREN ADirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074251 · ownership.xml · derivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 19, 2025 19:27 UTC |
DAWES KAREN ADirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074251 · ownership.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,096 F1 · shares: Ms. Dawes was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 19, 2025 19:05 UTC |
Madaus Martin DDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074224 · ownership.xml · derivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 19, 2025 19:05 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074224 · ownership.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,586 F1 · shares: Mr. Madaus was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 19, 2025 18:59 UTC |
Pax MargaretDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074216 · ownership.xml · derivative · entry 2 Pax Margaret · CIK 0001999772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 19, 2025 18:59 UTC |
Pax MargaretDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074216 · ownership.xml · nonDerivative · entry 1 Pax Margaret · CIK 0001999772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,016 F1 · shares: Ms. Pax was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 19, 2025 18:38 UTC |
Mhatre RohinDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-074196 · ownership.xml · derivative · entry 2 Mhatre Rohin · CIK 0001798735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 19, 2025 18:38 UTC |
Mhatre RohinDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074196 · ownership.xml · nonDerivative · entry 1 Mhatre Rohin · CIK 0001798735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,019 F1 · shares: Mr. Mhatre was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2025 Filed May 21, 2025 19:00 UTC |
BARTHELEMY NICOLASDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $123.26 | $0.00 |
DisclosureSEC source: 0000950170-25-075705 · ownership.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2035-05-15 F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 15, 2025 Filed May 21, 2025 19:00 UTC |
BARTHELEMY NICOLASDirector
|
GrantCommon Stock | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075705 · ownership.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,441 F1 · shares: Mr. Barthelemy was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 14:33 UTC |
Bylund JamesChief Operating Officer
|
Tax withholdingCommon Stock | 454 | $128.50 | $58,339.00 |
DisclosureSEC source: 0000950170-25-048942 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,711 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 19:58 UTC |
Pax MargaretDirector
|
PurchaseCommon Stock | 250 | $150.69 | $37,672.50 |
DisclosureSEC source: 0000950170-25-041119 · ownership.xml · nonDerivative · entry 1 Pax Margaret · CIK 0001999772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,043 Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,756 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · derivative · entry 10 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,756 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $33.87 | $0.00 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · derivative · entry 9 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,344 Underlying: Common Stock · 5,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 2,283 | $153.70 | $350,897.10 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 8 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,301 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F6 · price: $153.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.55 to $153.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 15,619 | $152.82 | $2,386,895.58 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 7 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,584 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F5 · price: $152.82 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.39 to $153.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 6,176 | $151.96 | $938,504.96 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 6 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,203 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F4 · price: $151.96 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.43 to $152.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 2,518 | $151.09 | $380,444.62 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 5 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,379 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F3 · price: $151.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.42 to $151.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 100 | $150.38 | $15,038.00 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 4 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,897 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
SaleCommon Stock | 60 | $148.05 | $8,883.00 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,997 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024. F2 · price: $148.05 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.01 to $148.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
Exercise / conversionCommon Stock | 21,756 | $59.52 | $1,294,917.12 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 163,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:21 UTC |
Hunt AnthonyDirector
|
Exercise / conversionCommon Stock | 5,000 | $33.87 | $169,350.00 |
DisclosureSEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2025 Filed Mar 20, 2025 17:51 UTC |
Bylund JamesChief Operating Officer
|
Tax withholdingCommon Stock | 175 | $142.44 | $24,927.00 |
DisclosureSEC source: 0000950170-25-042471 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,165 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units. Read SEC document |
| March 13, 2025 Filed Mar 20, 2025 17:51 UTC |
Bylund JamesChief Operating Officer
|
GrantCommon Stock | 381 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-042471 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,340 F1 · shares: Represents 63 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on May 16, 2023, and 318 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on December 12, 2023. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:42 UTC | GrantStock Option (Right to Buy) · Derivative | 6,056 | $0.00 Strike: $155.38 | $0.00 |
DisclosureSEC source: 0000950170-25-031593 · ownership.xml · derivative · entry 2 Garland Jason K · CIK 0001754555 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,056 Underlying: Common Stock · 6,056 shares Expires 2035-03-03 F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028. Read SEC document |
|
| March 03, 2025 Filed Mar 4, 2025 18:42 UTC | GrantCommon Stock | 6,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031593 · ownership.xml · nonDerivative · entry 1 Garland Jason K · CIK 0001754555 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,795 F1 · shares: Mr. Garland was awarded 6,435 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
|
| March 03, 2025 Filed Mar 4, 2025 18:41 UTC |
KURIYEL RALFSenior VP, R&D
|
GrantStock Option (Right to Buy) · Derivative | 4,542 | $0.00 Strike: $155.38 | $0.00 |
DisclosureSEC source: 0000950170-25-031591 · ownership.xml · derivative · entry 3 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,542 Underlying: Common Stock · 4,542 shares Expires 2035-03-03 F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:41 UTC |
KURIYEL RALFSenior VP, R&D
|
Tax withholdingCommon Stock | 386 | $155.38 | $59,976.68 |
DisclosureSEC source: 0000950170-25-031591 · ownership.xml · nonDerivative · entry 2 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,062 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:41 UTC |
KURIYEL RALFSenior VP, R&D
|
GrantCommon Stock | 4,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031591 · ownership.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,448 F1 · shares: Mr. Kuriyel was awarded 4,826 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:30 UTC |
Hunt AnthonyDirector
|
Tax withholdingCommon Stock | 10,142 | $155.38 | $1,575,863.96 |
DisclosureSEC source: 0000950170-25-031572 · ownership.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,301 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:29 UTC |
Bylund JamesChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,056 | $0.00 Strike: $155.38 | $0.00 |
DisclosureSEC source: 0000950170-25-031569 · ownership.xml · derivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,056 Underlying: Common Stock · 6,056 shares Expires 2035-03-03 F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:29 UTC |
Bylund JamesChief Operating Officer
|
Tax withholdingCommon Stock | 1,239 | $155.38 | $192,515.82 |
DisclosureSEC source: 0000950170-25-031569 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,959 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:29 UTC |
Bylund JamesChief Operating Officer
|
GrantCommon Stock | 6,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031569 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,198 F1 · shares: Mr. Bylund was awarded 6,435 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.